- Shift Into High-Quality Stocks Could Move Market Higher
- Military Arms Race Dominates Dubai Air Show
- China: Low US Interest Rates Threaten Recovery
- Cramer: 5 Earnings Reports to Watch Next Week
- Hedge Fund Billionaire Paulson Reports New Citi Stake
- Court Rejects 'Clawbacks' for Alleged Stanford Victims
- Cities With the Most Home Price Reductions
- This Year's Biggest Thanksgiving Leftover: Cash
- Oil Next Week: What Traders Will Be Watching
- U.S. Stocks Rally for the Second Straight Week
- Dollar is Not Plunging—So 'Calm Down': Market Strategist
- Strategists Say Markets Have More Upside — But How Much?
- Hirschhorn: Risk-Averse Traders
- Roginsky: A Funny Thing Happened on the Way to Financial Reform
- This Year's Biggest Thanksgiving Leftover: Cash
- TV Series Inks Unique Deal For Fight
- First Time Buyers Rescue Housing: Realtors
- Dollar General Trades Higher After Its IPO
MOST SHARED
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- CNBC TRANSCRIPT: Warren Buffett & Bill Gates - Keeping America Great
- Analysis: APEC Nations Back Face-Saving Climate Plan
- Israel Going Green
- China's Role as Lender Alters Dynamics for United States
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- Has Twitter's Finest Hours (Seconds) Come and Gone?
- Texas Man Drives Bugatti Into Pond; Blames Bird
Text Size 
Analyst actions and clinical trial data were some of the catalysts behind the most actively traded stocks on Wednesday.
Shares of Bristol-Myers Squibb [BMY
Loading...
()
] rose after Citigroup upgraded the stock to "buy" from "hold" and said Wall Street is underestimating the company's ability to widen profit margins.
In addition, analyst George Grofik said consensus margin forecasts -- well below the industry average -- leave room for improvement as Plavix sales continue to grow. And while a potential takeover of Bristol has a low probability of happening, the analyst said, a deal would warrant a takeout price of about $35 to $40 a share.
"In light of recent weakness, we believe Bristol-Myers shares represent a compelling risk-reward proposition," said Grofik.
Ford Motor [MDVN
Loading...
()
] shares rose on news the automaker was selling its Jaguar and Land Rover brands. The Dearborn, Mich.-based company has suggested in the past that it would consider selling the two British brands, and on Tuesday said it was reviewing its position on them.
Network equipment maker Finisar [FNSR
Loading...
()
] reaffirmed its first-quarter revenue forecast on Tuesday after the close of trading, sending shares higher Wednesday. The company said during a conference call with analysts that it expects revenue of $105 million to $112 million in the first quarter. Analysts expect the Sunnyvale, Calif.-based company to post revenue of $107.3 million.
Lawson Software [LWSN
Loading...
()
] gained 7% on Wednesday after the business application software maker raised forecasts for the fourth quarter. Lawson raised its quarterly earnings estimate by 2 cents a share and raised revenue guidance above Wall Street expectations.
Among downside movers, HealthSpring [HS
Loading...
()
] fell on heavy trading volume after the managed healthcare provider cut 2007 earnings estimates, citing higher-than-expected medical service costs and facility charges.
Print
Email
- Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
- For the chief of cable company Comcast, growth has been about making deals – generally very large deals.
- Some companies may start using insurance to shift carbon risk from their balance sheets to maybe... yours?
- The president and founder of Genesis Today wants to improve America’s health, and thinks Wal-Mart can help.
- Switzerland's privacy watchdog is taking legal action to force Google to make changes to its Street View service.
- A wealthy, distracted Texas driver crashed his million-dollar Bugatti Veyron sports car into a salt marsh, say police.
Data is a real-time snapshot *Data is delayed at least 15 minutes